Treat cancer with IV vitamin C - Recent clinical success

The use of IV (intravenous) vitamin C to treat cancer is growing in popularity around the world as positive research continues to accumulate and build a strong case for its effectiveness. The latest cohort study out of Germany is one more example, showing that IV vitamin C markedly improves the quality of life for breast cancer patients. Such positive results are likely the reason why many thousands of patients worldwide elect to be treated with this therapy every year.

 VITAMIN C I.V 100ml Bottle High Dose 

Romania, Europe

Contact: +40723141550 (whatsapp &viber)

Authorized supplier: Alexandru Calin 

(Licensed in Chemistry) 

Email: order.gerovital@gmail.com

Bucharest, Romania, Europe

PRICE: 30USD/Bottle 100ml

(10grams Ascorbic Acid)

Payments accepted:

- Secure Bank Transfer 

(from your bank account to ours)

- Credit Card 

(using international transfer systems like Transfast or Western Union)

1ml contains 100mg Ascorbic Acid

DISPOSABLE INFUSION SET - metalic spike

for Vitamin C IV Therapy 

Price: 10USD/set 

IV Vitamin C for Cancer: Current Status

It is now well established that by injecting vitamin C we can safely reach concentrations at which ascorbate generates hydrogen peroxide (H2O2) in tissues, and it is the H2O2 that selectively kills cancer cells through oxidative stress. Laboratory studies have confirmed that high-dose vitamin C is cytotoxic to a wide variety of cancer cell lines, and that it also boosts the anti-cancer activity of several common chemotherapy drugs. In animal models (rats), IV vitamin C has been shown to significantly decrease growth rates of liver, ovarian, pancreatic, and glioblastoma tumors with dosages easily achievable in humans. The science behind IV vitamin C as a cancer therapy is now so advanced that there are six clinical trials testing it (alone or with chemo drugs) in human patients against lymphoma and cancers of the colon, breast, uterus, cervix, prostate, pancreas and others.

IV Vitamin C Helps Cancer Patients: Clinical Evidence

Clinical trials have not yet shown IV vitamin C to shrink tumours, but that's no reason for an oncologist to reject this therapy. Improving quality of life is also an important goal of cancer treatment, and clinical experience shows IV vitamin C does exactly that. A prospective study from Korea (2007) showed that this therapy significantly improved quality of life for terminal cancer patients, bringing the global health/quality of life score from 36 to 55 and yielding improvements in physical, emotional, and cognitive functions. Disease symptom severity also decreased across the board, with patients showing significantly less fatigue, nausea/vomiting, pain, and appetite loss.

These results were echoed in a study just completed in late 2011 in Germany, which compared breast cancer patients receiving IV Vitamin C and standard therapy together, versus standard therapy alone. Those receiving IV vitamin C experienced a marked reduction (nearly 50%) in unpleasant symptoms and chemo/radiotherapy side effects such as loss of appetite, fatigue, depression, sleep disorders, dizziness and haemorrhagic diathesis.

The Use of IV Vitamin C is More Widespread Than You Think

Experiences such as those above are bringing more patients to try IV vitamin C - as are high profile patients. For example, the celebrated New Zealand physicist Sir Paul Callaghan elected to treat his colon cancer with IV vitamin C, and his CEA level (a colon cancer marker) started to decrease after only six infusions. This therapy is already widespread in New Zealand: 30 clinics provide it, administering about 10,000 vitamin C injections annually. In the US, a recent survey showed that over 8800 patients were treated with IV vitamin C in 2008, using a total of 355,000 dosage vials. But that was just for the health care practitioners taking part in the survey. For the same year, manufacturers reported sales of 855,000 vials of vitamin C. This implies that as many as 21,000 patients received IV vitamin C therapy in 2008.

Ongoing clinical trials using IV vitamin C to treat cancer won't complete until 2013 to 2014. But until then, clinical evidence already shows that this therapy can - at the very least - significantly improve cancer patients' quality of life. Oncologists should therefore strongly consider adding this therapy to their standard clinical practice.

High Dose IV Vitamin C

When administered intravenously, Vitamin C (ascorbic acid) is preferentially toxic to cancer cells. Given in high enough doses to maintain plasma concentrations above levels that have been shown to be toxic to tumor cells in vitro, Vitamin C has the ability to selectively kill cancer cells in a manner similar to other tumor cytotoxic chemotherapy drugs. Vitamin C does not exhibit toxicity to non-cancerous human cells, making it an attractive option in cancer therapy.

 VITAMIN C I.V 100ml Bottle High Dose 

Romania, Europe

Contact: +40723141550 (whatsapp &viber)

Authorized supplier: Alexandru Calin 

(Licensed in Chemistry) 

Email: order.gerovital@gmail.com

Bucharest, Romania, Europe

PRICE: 35USD/Bottle 100ml

(10grams Ascorbic Acid)

Payments accepted:

- Secure Bank Transfer 
(from your bank account to ours)

- Credit Card using international transfer systems like Transfast or Western Union

DISPOSABLE INFUSION SET - metalic spike

for Vitamin C IV Therapy

Price: 10USD/set

 

Vitamin C has also been shown to enhance the cytotoxicty (cancer killing effect) of several conventional chemotherapy drugs and reducing some of the many side effects of others when used as an adjunctive treatment.

In addition to these benefits, Intravenous Vitamin C therapy has been shown to reduce fatigue, pain, nausea, appetite loss, depression and sleep issues often associated with cancer.

A typical course of Intravenous Vitamin C treatment would  be 1 to 3 times per week as follows:

1st Treatment: 15 grams + lab testing

2nd Treatment : 30 grams

3rd Treatment: 60 grams

4th and subsequent Treatment: 75 grams 1-3 times per week

History

As far back as the 1970′s 2 time Nobel laureate Linus Pauling and his colleagues had been promoting the use of Vitamin C as a cancer treatment. The first clinical trial of Pauling and Cameron suggested that very high doses of Vitamin C (10g per day) administered intravenously was helpful in increasing survival time and improving quality of life in terminal cancer patients. Following this, two studies done at the Mayo clinic failed to reproduce their results when using 10 g of Vitamin C orally. Of course now we know that oral administration of Vitamin C does not increase blood levels to the level required to kill cancer cells. This is only achievable through IV administration. For example, oral Vitamin C (18 g per day) gives a blood level of up to 220 umol/L. IV Vitamin C (10 g) gives a blood level of approximately 5000 umol/L, or an approximately 25 fold increase.

Since the time of Pauling and Cameron, there has been many studies done on Vitamin C as a potential chemotherapeutic agent. Emerging research is showing that Vitamin C given by the intravenous route may function as an effective cancer therapy.

How It Works:
Vitamin C is involved in many aspects of host resistance to cancer, and it has been known for many years that cancer patients have decreased circulating and tissue levels of vitamin C.

When given in high enough doses, Vitamin C inhibits cell division and growth through the production of hydrogen peroxide (H202) outside of cancer cells in the intracellular space. Normal, healthy cells contain an enzyme called catalase, which quickly and easily breaks down hydrogen peroxide into water and oxygen. Cancer cells, however, lack this enzyme and therefore the ability to neutralize hydrogen peroxide. As a result, hydrogen peroxide builds up in the connective tissue surrounding tumour cells, killing them or inhibiting their growth while leaving normal cells intact.

From a patient’s perspective, I most often hear reports of having more energy, increased appetite and better overall mood for up to 1 week following treatment. IV Vitamin C treatments can significantly improve quality of life of cancer patients and prolong expected survival times.

Recent research has also found that intravenous Vitamin C does not interfere with the activity of many important chemotherapeutic drugs. In fact it has been shown to reinforce their activity and decrease the side effects of conventional chemotherapy treatments.

Vitamin C Intravenous kills Cancer cells

By now, most people know that vitamin C is a potent antioxidant that has the power to boost immune function, increase resistance to infection, and protect against a wide range of diseases.

 

 VITAMIN C I.V 100ml Bottle High Dose 

Romania, Europe

Contact: +40723141550 (whatsapp &viber)

Authorized supplier: Alexandru Calin 

(Licensed in Chemistry) 

Email: order.gerovital@gmail.com

Bucharest, Romania, Europe

PRICE: 35USD/Bottle 100ml

(10grams Ascorbic Acid)

Payments accepted:

- Secure Bank Transfer (from your bank account to ours)

- Credit Card using international transfer systems like Wise, Remitly or Western Union

  DISPOSABLE INFUSION SET - metalic spike

for Vitamin C IV Therapy 

Price: 10USD/set 

But there’s an entirely different and largely unknown role of vitamin C, and that is its ability—when administered in very high doses by intravenous (IV) infusions—to kill cancer cells.

Vitamin C interacts with iron and other metals to create hydrogen peroxide. In high concentrations, hydrogen peroxide damages the DNA and mitochondria of cancer cells, shuts down their energy supply, and kills them outright. Best of all—and unlike virtually all conventional chemotherapy drugs that destroy cancer cells—it is selectively toxic. No matter how high the concentration, vitamin C does not harm healthy cells.

Lab studies reveal that this therapy is effective against many types of cancer, including lung, brain, colon, breast, pancreatic, and ovarian. Animal studies show that when human cancers are grafted into animals, high-dose IV vitamin C decreases tumor size by 41 to 53 percent “in diverse cancer types known for both their aggressive growth and limited treatment options.” Additionally, numerous patient case reports have been written up in medical journals.

Why IV Administration Is Essential 

The only way to get blood levels of vitamin C to the concentrations required to kill cancer cells is to administer it intravenously. The body tightly controls levels of this vitamin by limiting intestinal absorption. If you took 10 g (10,000 mg) of vitamin C by mouth at one time, you would only absorb around 500 mg—and you’d get a serious case of diarrhea! 

Intravenous administration, however, bypasses this control mechanism, and blood levels rise in a dose-dependent manner. For example, 10 g of IV vitamin C raises blood levels 25 times higher than the same dose taken orally, and this increases up to 70-fold as doses get larger.